ARCHIVES

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 10 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

President Asks $600 Million For NCI In ’75; Research Grants Would Get $19 Million Hike

February 8, 1974

DCPC Board Ok’s Grant Programs In Prevention, Public Education

October 30, 1992

NCI Separates Carcinogenesis Research Efforts

February 18, 1977

Pilot Study Tests Novel “Metronomic” Delivery

December 30, 2005

“With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.”

July 7, 1995

ACS Seeks Applications For Clinical Awards

January 1, 1993